Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma

Abstract

Interleukin-10 (IL-10) is a cytokine that is produced by a variety of immune cells and is known to inhibit T helper cell type 1 (TH1) responses, which are essential to combat tumors. In the present study, we used LSA, a T cell lymphoma cell line that expresses IL-10, to study the role of this cytokine in its tumorigenesis. To this end, LSA cells were modified to overexpress IL-10 or to block its expression via Ret-off-IL-10 vector transfection. Interestingly, blocking IL-10 expression using Ret-off-IL-10 antisense inhibited the growth of LSA in syngeneic C57BL/6 mice. Also, overexpression of IL-10 in LSA cells using Ret-off-IL-10 sense significantly increased LSA tumorigenicity. Additionally, administration of antibodies against IL-10 significantly inhibited LSA tumor growth in vivo. Together, our data stress the importance of tumor-produced IL-10 in regulating the tumorigenicity of this T cell lymphoma, and suggest that antagonizing IL-10 expression in IL-10 secreting lymphomas may have significant potential in their treatment.

Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity

“…These data demonstrated that Nrp-1 inhibited CD8a + protein expression in tumor tissues and limited its function (CD8 + IFN-γ + ). The mouse spleen-derived DC (spDC) activation and maturation status were assessed using flow cytometry 23 . Significantly more mature CD11b + CD11c hi (mDC) cells were detected in IL-10 knockout tumor-bearing mice compared with WT mice (mDC, Fig.…”

Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas

“…Mona R. Hassuneh et al used LSA (a T-cell lymphoma cell line expressing IL-10) to study the role of IL-10 in tumorigenesis. Interestingly, the administration of anti-IL-10 antibodies significantly inhibited the growth of tumors in LSA ( 31 ).…”

Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease

“…Since TGF␤1 can induce regulatory T-cells (Tregs), which make IL-10, this particular anti-inflammatory action of TGF␤1 is most likely mediated through the induction of Tregs in vivo [70,71]. Interleukin (IL)-10 has anti-inflammatory properties that is encoded by the IL-10 gene in humans [72]. IL-10 blocks NF-B activation, enhances B cell survival, proliferation, antibody production, and furthermore, it can regulates the JAK-STAT signaling pathway [73,74].…”